GSK3A and colonic neoplasm: Notably, in the tumors of colon cancer patients grouped into high-GSK3α based on the best cutoff (Fig. 1B), the expression differences of GSK3α between tumors and DNTs were much more significant (Fig. 1C), although some stages were no longer significant after TNM staging, probably due to the limited number of samples.